ArticleJournal of neurology2023

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).

Tobias Monschein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.